Scientists test brain zapping methods on healthy volunteers
NCT ID NCT03351764
First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 9 times
Summary
This study tested different ways to apply non-invasive brain stimulation (like magnetic pulses) in 83 healthy adults aged 18-65. The goal was to learn how to make these techniques more effective for diagnosing and treating brain disorders. Participants completed tasks, had brain scans, and wore electrodes to measure brain and muscle activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
83 people
The number who actually took part.
- Started
-
Jan 2018
- Finished
-
Dec 2025
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA (for all substudies): * Male and female subjects between 18 and 65 years of age. * Subjects must be able to give written informed consent prior to participation in this study. * All subjects must have undergone a screening assessment under protocol 01-M-0254, The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers or under protocol 17-M-0181 (Recruitment and Characterization of Research Volunteers for NIMH Intramural Studies). * For cognitive experiments utilizing language stimuli only native English speakers will be enrolled. EXCLUSION CRITERIA (for all substudies): * Women who are pregnant or breastfeeding. * History of any Axis I DSM-5 disorder, except alcohol abuse outside of one year. * History of seizure (childhood febrile seizures are acceptable and these subjects may be included in the study), history of epilepsy in self or first degree relatives, stroke, brain surgery, known structural brain lesion, or with history of any head trauma within 6 months of screening, or, beyond 6 months prior to screening, history of head trauma with evidence of traumatic abnormality appearing on their brain scan, or with loss of consciousness \>5 min, or with other sequelae, excluding headache, lasting \>24 hours. * Increased risk of seizure for any reason, including prior diagnosis of increased intracranial pressure (such as after large infarctions or trauma), or currently taking medication that lowers the seizure threshold. Excluded medications and substances include: imipramine, amitriptyline, doxepine, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, cocaine, (MDMA, ecstasy), phencyclidine (PCP, angel s dust), ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline. * A history of drug or alcohol abuse within 1 year or a lifetime history of drug or alcohol dependence (DSM-5 criteria). * Presence of ferromagnetic metal in the body, for example metallic (ferromagnetic) implants (e.g, heart pacemaker, aneurysm clip). * Subjects with an unstable or serious medical or neurological disorder. * No concurrent medications, such as psychotropic drugs, that affect brain function. * Presence of any medical illness likely to alter brain morphology and/or physiology (e.g., hypertension, diabetes) even if controlled by medications. * Positive test for HIV. * Subjects who have hearing loss that has been clinically evaluated and diagnosed. * Participants who are uncomfortable in small closed spaces (have claustrophobia), unable to lie comfortably supine for up to 60 minutes, and would feel uncomfortable in the MRI machine (for subjects doing imaging component of the study only). * A current NIMH employee or staff or their immediate family member. * Participant is concurrently participating in another substudy in this protocol, or in any other study involving NIBS.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Normal physiology are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your pupils reveal how light shapes sleep—and why age and sex matter
- Healthy donors needed for research sample bank
- Nicotine's brain impact on depression under the microscope
- Scientists lock volunteers in rooms to measure how many calories they burn after eating
- Brain test could revolutionize alcohol addiction treatment
- Healthy brains scanned twice to test reliability of imaging methods